Overview
Massive blood loss occurs in metastatic spinal tumor resection and may cause severe complications. The objective of this study is to investigate whether the use of tranexamic acid will reduce perioperative and postoperative bleeding when compared to those without use of tranexamic acid.
Eligibility
Inclusion Criteria:
- Diagnosed as metastatic carcinoma of the thoracolumbar spine
- solitary neoplasm involve only one segment of spine
- patients underwent separation surgery
Exclusion Criteria:
- coagulation function was abnormal preoperatively
- patients are allergic to tranexamic acid
- neoplasm involve more than one segment of spine
- patients with rich blood supply who need embolization